Detalhe da pesquisa
1.
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma.
Blood Adv
; 7(2): 236-245, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251745
2.
Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma.
Cancer Res
; 83(8): 1214-1233, 2023 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779841
3.
Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy.
Leukemia
; 35(8): 2346-2357, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33479469
4.
Co-evolution of tumor and immune cells during progression of multiple myeloma.
Nat Commun
; 12(1): 2559, 2021 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33963182
5.
Evolution and structure of clinically relevant gene fusions in multiple myeloma.
Nat Commun
; 11(1): 2666, 2020 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32471990
6.
Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma.
Cancers (Basel)
; 12(2)2020 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32012878
7.
Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma.
Nat Commun
; 11(1): 6037, 2020 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33247158
8.
Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma.
J Control Release
; 270: 158-176, 2018 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29196043
9.
Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy.
Blood Cancer J
; 9(9): 68, 2019 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31431613
10.
The efficacy of salvage autologous stem cell transplant among patients with multiple myeloma who received maintenance therapy post initial transplant.
Bone Marrow Transplant
; 53(11): 1483-1486, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29795420